Cargando…
Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
The role of cholecystokinin (CCK) has been explored in pancreatic carcinogenesis following pancreatobiliary diversion (PBD), using the specific CCK receptor antagonist CR-1409. Male Wistar rats (n = 80) weighing 70-100 g were given weekly i.p. injections of azaserine (30 mg kg-1 week-1) for 3 consec...
Autores principales: | Watanapa, P., Flaks, B., Oztas, H., Deprez, P. H., Calam, J., Williamson, R. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968354/ https://www.ncbi.nlm.nih.gov/pubmed/8471422 |
Ejemplares similares
-
Pancreatobiliary diversion enhances experimental pancreatic carcinogenesis.
por: Stewart, I. D., et al.
Publicado: (1991) -
Enhancing effect of partial gastrectomy on pancreatic carcinogenesis.
por: Watanapa, P., et al.
Publicado: (1992) -
Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
por: Howatson, A. G., et al.
Publicado: (1985) -
Histogenesis of pancreatic carcinogenesis in the hamster: ultrastructural evidence.
por: Flaks, B
Publicado: (1984) -
Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.
por: Appel, M. J., et al.
Publicado: (1992)